Delivery Order SPE2DX22D0049-SPE2D826FA4AK
- Not listed
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $128,180.25 on January 15, 2026, by the Defense Logistics Agency Medical Supply Chain. The contract utilizes firm fixed-price pricing with an ultimate completion date of January 16, 2026, and was competitively awarded without any set-aside designation. This delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract with...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $415,041.13 on January 26, 2026, by the Defense Logistics Agency's Medical Supply Chain. The competitively awarded, firm fixed-price contract represents a child order under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,127.28 on January 29, 2026, by the Defense Logistics Agency's Medical Supply Chain. The contract is classified as a firm fixed-price delivery order with an ultimate completion date of January 30, 2026, and utilizes no set-aside designation, indicating it was competitively awarded. This delivery order represents a task order issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $1,045.70 by the Defense Logistics Agency's Medical Supply Chain division. This competitively awarded, non-set-aside contract carries a firm fixed price structure with an ultimate completion date of February 3, 2026. The award represents a task order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $135,934.08 by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price contract, awarded on January 15, 2026, with an ultimate completion date of January 16, 2026, represents a competitive award with no set-aside designation. The award falls under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $67,847.22 by the Defense Logistics Agency's Medical Supply Chain on February 2, 2026, with an ultimate completion date of February 3, 2026. This competitively awarded, firm fixed-price contract represents a child delivery order under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $11,878.08 by the Defense Logistics Agency's Medical Supply Chain on January 28, 2026. This non-set-aside, competitively awarded contract operates under a firm fixed-price structure with an ultimate completion date of January 29, 2026. The delivery order is issued under Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with DLA Troop...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $149,401.15 by the Defense Logistics Agency's Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract that leverages the company's existing Indefinite Delivery Contract with DLA Troop Support Medical valued at up to...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $152,520 on February 2, 2026, by the Defense Logistics Agency Medical Supply Chain. This competitively awarded, firm fixed-price contract with an ultimate completion date of February 3, 2026 carries no set-aside designation. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,011.99 by the Defense Logistics Agency's Medical Supply Chain on January 12, 2026, with an ultimate completion date of January 13, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support...
- SPE2DX22D0049Indefinite Delivery Contract
- SPE2DX22D0049-SPE2D826FA4AKDelivery Order
Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $650,959.80 by the Defense Logistics Agency's Medical Supply Chain on February 2, 2026, with an ultimate completion date of February 3, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a task order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026. The underlying IDC serves as a comprehensive global pharmaceutical support vehicle enabling Amerisourcebergen to supply an extensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains to support military healthcare programs worldwide. This delivery order is executed by Amerisourcebergen Drug Corp as a child entity under its parent organization, Cencora, Inc. (doing business as Amerisourcebergen), which holds the primary $999,999,999.00 Indefinite Delivery Contract with DLA. The award demonstrates Amerisourcebergen's continued capability to meet federal procurement requirements through competitive bidding and reflects the company's critical role in supplying essential pharmaceutical and medical commodities to the Defense Health Agency and other federal healthcare systems supporting military treatment facilities and veteran healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $651.0k | 2/1/26 |